Overview

Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer

Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This Phase II randomized study is to determine the efficacy of split-course irradiation with concurrent chemotherapy in locoregional recurrence of non-small cell lung cancer after surgical resection
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Docetaxel
Pemetrexed